Alger Russell Innovation ETF (INVN)
NYSEARCA: INVN · Real-Time Price · USD
18.90
+0.15 (0.78%)
Mar 16, 2026, 4:00 PM EDT - Market closed
0.78% (1D)
| Assets | $10.86M |
| Expense Ratio | 0.55% |
| PE Ratio | 19.22 |
| Shares Out | 575,000 |
| Dividend (ttm) | $0.06 |
| Dividend Yield | 0.33% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 6.35% |
| Volume | 25 |
| Open | 18.90 |
| Previous Close | 18.75 |
| Day's Range | 18.90 - 18.90 |
| 52-Week Low | 15.37 |
| 52-Week High | 22.34 |
| Beta | n/a |
| Holdings | 51 |
| Inception Date | Jan 6, 2025 |
About INVN
Fund Home PageThe Alger Russell Innovation ETF (INVN) is an exchange-traded fund that is based on the Alger Russell Innovation index. The fund tracks an equal-weighted index of 50 US stocks selected from the Russell 1000 through a fundamental approach. The fund seeks to identify companies at the forefront of innovation. INVN was launched on Jan 6, 2025 and is issued by Alger.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol INVN
ETF Provider Alger
Index Tracked Alger Russell Innovation Index
Top 10 Holdings
26.59% of assets| Name | Symbol | Weight |
|---|---|---|
| Enphase Energy, Inc. | ENPH | 3.33% |
| RingCentral, Inc. | RNG | 2.98% |
| F5, Inc. | FFIV | 2.70% |
| Bristol-Myers Squibb Company | BMY | 2.65% |
| Merck & Co., Inc. | MRK | 2.60% |
| BioMarin Pharmaceutical Inc. | BMRN | 2.50% |
| Cirrus Logic, Inc. | CRUS | 2.49% |
| Jazz Pharmaceuticals plc | JAZZ | 2.47% |
| Align Technology, Inc. | ALGN | 2.47% |
| Pfizer Inc. | PFE | 2.41% |
Performance
INVN had a total return of 3.42% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.45%.
